• Fri, November 2, 2018

by: WOPRAI

Jason Gerberry Maintained (TEVA) at Sell with Increased Target to $20 on, Nov 2nd, 2018

by: WOPRAI

Richard Eastman Maintained (TRMB) at Buy with Increased Target to $47 on, Nov 2nd, 2018

by: WOPRAI

Tiffany Kanaga Upgraded (BKE) to Hold and Held Target at $19 on, Nov 2nd, 2018

by: WOPRAI

Jack Meehan Maintained (BIO) at Hold with Decreased Target to $315 on, Nov 2nd, 2018

by: WOPRAI

Rob Oliver Maintained (TYL) at Buy with Decreased Target to $250 on, Nov 2nd, 2018

by: WOPRAI

Jeffrey Meuler Maintained (ATGE) at Hold with Increased Target to $54 on, Nov 2nd, 2018

by: WOPRAI

John Kim Upgraded (AVB) to Buy on, Nov 2nd, 2018

by: WOPRAI

Kenneth Zener Upgraded (AWI) to Buy and Held Target at $76 on, Nov 2nd, 2018

by: WOPRAI

Seth Basham Maintained (W) at Hold with Decreased Target to $100 on, Nov 2nd, 2018

by: WOPRAI

Nicholas Jones Maintained (W) at Hold with Decreased Target to $105 on, Nov 2nd, 2018

by: WOPRAI

Christopher Horvers Maintained (W) at Hold with Decreased Target to $110 on, Nov 2nd, 2018

by: WOPRAI

Colin Sebastian Maintained (W) at Hold with Decreased Target to $108 on, Nov 2nd, 2018

by: WOPRAI

Michael Carroll Downgraded (VTR) to Hold and Held Target at $59 on, Nov 2nd, 2018

by: WOPRAI

Sterling Auty Upgraded (VRSN) to Hold and Increased Target to $160 on, Nov 2nd, 2018

by: WOPRAI

Walter Pritchard Maintained (VRSN) at Hold with Increased Target to $155 on, Nov 2nd, 2018

by: WOPRAI

Sterling Auty Maintained (VRSN) at Hold with Increased Target to $160 on, Nov 2nd, 2018

by: WOPRAI

Christian Wetherbee Maintained (SNDR) at Hold with Decreased Target to $25 on, Nov 2nd, 2018

by: WOPRAI

Brian Ossenbeck Maintained (SNDR) at Buy with Decreased Target to $27 on, Nov 2nd, 2018

by: WOPRAI

Benjamin Hartford Maintained (SNDR) at Buy with Decreased Target to $28 on, Nov 2nd, 2018

by: WOPRAI

Ken Hoexter Maintained (SNDR) at Sell with Decreased Target to $25 on, Nov 2nd, 2018

by: WOPRAI

Timothy Thein Maintained (AGCO) at Hold with Decreased Target to $64 on, Nov 2nd, 2018

by: WOPRAI

Jacob Kilstein Maintained (AIG) at Strong Buy with Decreased Target to $50 on, Nov 2nd, 2018

by: WOPRAI

David Ridley-Lane Maintained (CBRE) at Strong Buy with Decreased Target to $47 on, Nov 2nd, 2018

by: WOPRAI

Jonathan Raviv Maintained (CACI) at Strong Buy with Decreased Target to $205 on, Nov 2nd, 2018

by: WOPRAI

Edward Caso Maintained (CACI) at Buy with Increased Target to $210 on, Nov 2nd, 2018

by: WOPRAI

Steven Koenig Upgraded (ANSS) to Buy and Increased Target to $184 on, Nov 2nd, 2018

by: WOPRAI

Alex Kurtz Maintained (ANET) at Buy with Increased Target to $80 on, Nov 2nd, 2018

by: WOPRAI

Tim Long Maintained (ANET) at Buy with Increased Target to $74 on, Nov 2nd, 2018

by: WOPRAI

Jim Suva Maintained (ANET) at Strong Buy with Increased Target to $79 on, Nov 2nd, 2018

by: WOPRAI

Jeff Kvaal Maintained (ANET) at Hold with Increased Target to $65 on, Nov 2nd, 2018

by: WOPRAI

Rod Hall Maintained (ANET) at Hold with Increased Target to $66 on, Nov 2nd, 2018

by: WOPRAI

Joel Beatty Downgraded (AMRN) to Hold and Increased Target to $28 on, Nov 2nd, 2018

by: WOPRAI

Matthew Niknam Downgraded (AMT) to Hold on, Nov 2nd, 2018

by: WOPRAI

Youssef Squali Maintained (BABA) at Strong Buy with Decreased Target to $180 on, Nov 2nd, 2018

by: WOPRAI

Jasper Hellweg Upgraded (BAX) to Strong Buy and Held Target at $70 on, Nov 2nd, 2018

by: WOPRAI

James Naklicki Maintained (ALL) at Strong Buy with Decreased Target to $105 on, Nov 2nd, 2018

by: WOPRAI

Timothy Thein Maintained (ALSN) at Strong Buy with Decreased Target to $53 on, Nov 2nd, 2018

by: WOPRAI

Alexia Quadrani Maintained (AMCX) at Hold with Increased Target to $65 on, Nov 2nd, 2018

by: WOPRAI

Scott Graham Maintained (AME) at Buy with Decreased Target to $91 on, Nov 2nd, 2018

by: WOPRAI

Richard Eastman Maintained (AME) at Buy with Increased Target to $84 on, Nov 2nd, 2018

by: WOPRAI

Manav Patnaik Maintained (BFAM) at Buy with Increased Target to $125 on, Nov 2nd, 2018

by: WOPRAI

Andrew Steinerman Maintained (BFAM) at Buy with Increased Target to $125 on, Nov 2nd, 2018

by: WOPRAI

Jeffrey Meuler Maintained (BFAM) at Hold with Increased Target to $122 on, Nov 2nd, 2018

by: WOPRAI

Phillip Huang Maintained (BCE) at Buy with Decreased Target to $47 on, Nov 2nd, 2018

by: WOPRAI

Samik Chatterjee Maintained (VIAV) at Sell with Increased Target to $12 on, Nov 2nd, 2018

by: WOPRAI

Joseph France Maintained (USPH) at Hold with Increased Target to $107 on, Nov 2nd, 2018

by: WOPRAI

Jessica Fye Maintained (UTHR) at Hold with Increased Target to $126 on, Nov 2nd, 2018

by: WOPRAI

Wamsi Mohan Downgraded (AAPL) to Hold and Decreased Target to $55 on, Nov 2nd, 2018

Jessica Fye Maintained (UTHR) at Hold with Increased Target to $126 on, Nov 2nd, 2018

Jessica Fye of JP Morgan, Maintained "United Therapeutics Corporation" (UTHR) at Hold with Increased Target from $118 to $126 on, Nov 2nd, 2018.

Jessica has made no other calls on UTHR in the last 4 months.



There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, 0 agree with Jessica's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jessica

  • M. Auster of "Credit Suisse" Maintained at Sell with Decreased Target to $103 on, Thursday, November 1st, 2018
  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $253 on, Thursday, August 2nd, 2018

Like: 👍